title: Overexpression of PKCepsilon in R6 fibroblasts causes increased production of active TGFbeta.
abstract: In previous studies, our laboratory demonstrated that Rat 6 (R6) fibroblasts which stably overproduce high levels of PKCepsilon display abnormalities in growth control that are characteristic of malignant transformation (Cacace et al., 1993, Oncogene, 8:2095-2104). The R6-PKCepsilon overproducing cell lines also exhibited a decreased growth factor requirement. The present study demonstrates that conditioned medium (CM) from two individual clones, R6-PKCepsilon 10 and 30, stimulates DNA synthesis in control R6-C1 cells. Maximal DNA synthesis and morphologic transformation was achieved in control cells when they were treated with medium from R6-PKCepsilon cells grown in the presence of TPA (TPA-CM). Size fractionation of the TPA-CM from PKCepsilon 30 cells revealed that this activity is due to a factor(s) that has an apparent molecular weight in the range of 10-30 kD and is heat and acid stable. This factor, like TGFbeta1, stimulated anchorage-independent growth of NRK cells. Western blot analysis (under nonreducing conditions) of the TPA-CM from R6-PKCepsilon 30 and R6-PKCepsilon 10 cells revealed the presence of the 25 kD active forms of TGFbeta2 and 3. These active forms of TGFbeta were not found in the CM of control R6 cells, or R6 cells that overexpress PKCalpha or PKCbeta1. The addition of a pan-specific TGFbeta antibody to NRK cells treated with the 10-30 kD fraction of TPA-CM from PKCepsilon 30 cells blocked the ability of this material to stimulate thymidine incorporation. Taken together, these studies suggest that the oncogenic activity of PKCepsilon in R6 cells is due, at least in part, to its ability to induce production of the active forms of TGFbeta2 and 3.
authors.affiliation: Department of Pharmacology and Herbert Irving Comprehensive Cancer Center, Columbia Presbyterian Medical Center, Columbia University, New York, New York 10032, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Cacace
authors.forename: M
authors.initials: M
authors.lastname: Ueffing
authors.forename: E K
authors.initials: EK
authors.lastname: Han
authors.forename: D
authors.initials: D
authors.lastname: Marmè
authors.forename: I B
authors.initials: IB
authors.lastname: Weinstein
mesh_terms: D000818:Animals; D002448:Cell Adhesion; D002455:Cell Division; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D017077:Culture Media, Conditioned; D004247:DNA / Q000096:biosynthesis; D005347:Fibroblasts / Q000201:enzymology / Q000378:metabolism*; D007527:Isoenzymes / Q000235:genetics / Q000502:physiology*; D008934:Mitogens / Q000494:pharmacology; D008970:Molecular Weight; D011493:Protein Kinase C / Q000235:genetics / Q000502:physiology*; D051744:Protein Kinase C-epsilon; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics / Q000502:physiology*
chemical_list: D017077:Culture Media, Conditioned; D007527:Isoenzymes; D008934:Mitogens; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D004247:DNA; C497257:Prkce protein, rat; D011493:Protein Kinase C; D051744:Protein Kinase C-epsilon; D013755:Tetradecanoylphorbol Acetate